Abstract:Cytotoxic lymphocytes release proteins contained within the cytoplasmic cytolytic granules after recognition of infected or tumor target cells. These cytotoxic granular proteins (namely granzymes, granulysin, and perforin) are key immunological mediators within human cellular immunity. The availability of highly purified cytotoxic proteins has been fundamental for understanding their function in immunity and mechanistic involvement in sepsis and autoimmunity. Methods for recovery of native cytotoxic proteins can be problematic leading to: 1) the co-purification of additional proteins, confounding interpretation of function, and 2) low yields of highly purified proteins. Recombinant protein expression of individual cytolytic components can overcome these challenges. The use of mammalian expression systems is preferred for optimal post-translational modifications and avoidance of endotoxin contamination. Some of these proteins have been proposed for host directed human therapies (e.g. - granzyme A), or treatment of systemic infections or tumors as in granulysin. We report here a novel expression system using HEK293T cells for cost-effective purification of high yields of human granzymes (granzyme A and granzyme B) and granulysin with enhanced biological activity than previous reports. The resulting proteins are free of native contaminants, fold correctly, and remain enzymatically active. Importantly, these improvements have also led to the first purification of biologically active recombinant human granulysin in high yields from a mammalian system. This method can be used as a template for purification of many other secreted cellular proteins and may lead to advances for human medicine.

cDNA cloning and recombinant expression of human granulysin and preparation of antiserum

Preparation and identification of polyclonal antibody to granulysin

Expression, Purification and Bioactivity Analysis of Granulysin

Construction of recombinant expression vector of granulysin gene and its prokaryotic expression

Fermentation of Preparation of Recombinant Human Granulysin in Escherichia coli

Cloning,Purification and Prokaryotic Expression of Human Granzyme B Gene

Construction of a fusion gene expression vector containing human granulysin and green fluorescent protein gene and its expression in murine macrophage RAW264.7

Cloning, Expression and Polyclonal Antibody Preparation of UGRP1 and Its Subcellular Localization

Biological Function Analysis of Monoclonal Antibodies Against Human Granulins in Vitro Using U251 Cells As a Model.

Cloning, expression and cytotoxicity of granulin A, a novel polypeptide contained in human progranulin.

Construction and Expression of the Recombinant Attenuated Salmonella Carrying Human 9 Ku-Granulysin Gene

Cloning and Expressing of Golgi Protein73 Gene Fragment and Preparation of Monoclonal Antibodies Against the Recombinant Protein

Production and characterization of recombinant 9 and 15 kDa granulysin by fed-batch fermentation in Pichia pastoris

Preparation and Identification of the Rabbit Anti-human Immune-related Gene Guanosine Triphosphate Polyclonal Antibody

Preparation and identification of monoclonal antibody against human Grn E

Preparation and Characterization of Monoclonal Antibody Against Human Granulocytes

Eukaryotic Expression and Identification of Recombinant Shuttle Plasmid for Co-Expression of Human Granulysin Active Peptide and Murine IL-12

Improved Purification of Human Granzyme A/B and Granulysin Using a Mammalian Expression System

Cloning, characterization and expression of a cDNA encoding a granulin-like polypeptide in Ciona savignyi.

[Preparation and Characterization of Monoclonal Antibodies Against F Domain of Human Progranulin].

Identification and 99tcm Labelling of a Monoclonal Antibody Against Human Granulocytes